top of page
Latest on SGLT2 inhibitors
Application of SGLT2i in CKD: a call for action
What are the data on the use of SGLT2i in CKD?
When and how should SGLT2i be given in CKD?
01/03/2023
Initiation of SGLT2i in CKD: how, when and in whom?
Οι SGLT2i ίσως προσφέρουν νεφροπροστασία ακόμη και με eGFR <30
Therapeutic goals for patients with type 2 diabetes and CKD
Cardiovascular effects of canagliflozin
compared to finarenone
Meta-analysis of the effect of SGLT2i on renal function
14/07/2023
bottom of page